These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27602372)

  • 1. Current understanding of tyrosine kinase BMX in inflammation and its inhibitors.
    Qiu L; Wang F; Liu S; Chen XL
    Burns Trauma; 2014; 2(3):121-4. PubMed ID: 27602372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstitution of Btk signaling by the atypical tec family tyrosine kinases Bmx and Txk.
    Tomlinson MG; Kurosaki T; Berson AE; Fujii GH; Johnston JA; Bolen JB
    J Biol Chem; 1999 May; 274(19):13577-85. PubMed ID: 10224128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2.
    Tamagnone L; Lahtinen I; Mustonen T; Virtaneva K; Francis F; Muscatelli F; Alitalo R; Smith CI; Larsson C; Alitalo K
    Oncogene; 1994 Dec; 9(12):3683-8. PubMed ID: 7970727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tec kinases regulate T-lymphocyte development and function: new insights into the roles of Itk and Rlk/Txk.
    Readinger JA; Mueller KL; Venegas AM; Horai R; Schwartzberg PL
    Immunol Rev; 2009 Mar; 228(1):93-114. PubMed ID: 19290923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a Novel Class of Covalent Dual Inhibitors Targeting the Protein Kinases BMX and BTK.
    Forster M; Liang XJ; Schröder M; Gerstenecker S; Chaikuad A; Knapp S; Laufer S; Gehringer M
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tec family kinases in inflammation and disease.
    Horwood NJ; Urbaniak AM; Danks L
    Int Rev Immunol; 2012 Apr; 31(2):87-103. PubMed ID: 22449071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of the Tec-family tyrosine kinase SH3 domains.
    Roberts JM; Tarafdar S; Joseph RE; Andreotti AH; Smithgall TE; Engen JR; Wales TE
    Protein Sci; 2016 Apr; 25(4):852-64. PubMed ID: 26808198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMX and its role in inflammation, cardiovascular disease, and cancer.
    Cenni B; Gutmann S; Gottar-Guillier M
    Int Rev Immunol; 2012 Apr; 31(2):166-73. PubMed ID: 22449076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tec kinases in T cell and mast cell signaling.
    Felices M; Falk M; Kosaka Y; Berg LJ
    Adv Immunol; 2007; 93():145-84. PubMed ID: 17383541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of Bruton's tyrosine kinase (Btk) using short interfering RNA duplexes (siRNA).
    Heinonen JE; Smith CI; Nore BF
    FEBS Lett; 2002 Sep; 527(1-3):274-8. PubMed ID: 12220673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Tec family of cytoplasmic tyrosine kinases: mammalian Btk, Bmx, Itk, Tec, Txk and homologs in other species.
    Smith CI; Islam TC; Mattsson PT; Mohamed AJ; Nore BF; Vihinen M
    Bioessays; 2001 May; 23(5):436-46. PubMed ID: 11340625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predominant expression of murine Bmx tyrosine kinase in the granulo-monocytic lineage.
    Weil D; Power MA; Smith SI; Li CL
    Blood; 1997 Dec; 90(11):4332-40. PubMed ID: 9373244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A FLIPR-based assay to assess potency and selectivity of inhibitors of the TEC family kinases Btk and Itk.
    Douhan J; Miyashiro JS; Zhou X; Cole DC; Wu PW; Collins M; Dunussi-Joannopoulos K
    Assay Drug Dev Technol; 2007 Dec; 5(6):751-8. PubMed ID: 18181691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bruton tyrosine kinase (BTK) in X-linked agammaglobulinemia (XLA).
    Vihinen M; Mattsson PT; Smith CI
    Front Biosci; 2000 Dec; 5():D917-28. PubMed ID: 11102316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of Bruton's tyrosine kinase (BTK) inhibitors on collagen-induced platelet aggregation, BTK, and tyrosine kinase expressed in hepatocellular carcinoma (TEC).
    Chen J; Kinoshita T; Gururaja T; Sukbuntherng J; James D; Lu D; Whang J; Versele M; Chang BY
    Eur J Haematol; 2018 Jul; ():. PubMed ID: 30030853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phylogeny of Tec family kinases identification of a premetazoan origin of Btk, Bmx, Itk, Tec, Txk, and the Btk regulator SH3BP5.
    Ortutay C; Nore BF; Vihinen M; Smith CI
    Adv Genet; 2008; 64():51-80. PubMed ID: 19161832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Bmx tyrosine kinase is activated by IL-3 and G-CSF in a PI-3K dependent manner.
    Ekman N; Arighi E; Rajantie I; Saharinen P; Ristimäki A; Silvennoinen O; Alitalo K
    Oncogene; 2000 Aug; 19(36):4151-8. PubMed ID: 10962576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Tec family kinases in myeloid cells.
    Schmidt U; Boucheron N; Unger B; Ellmeier W
    Int Arch Allergy Immunol; 2004 May; 134(1):65-78. PubMed ID: 15133303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TEC family kinases in health and disease--loss-of-function of BTK and ITK and the gain-of-function fusions ITK-SYK and BTK-SYK.
    Hussain A; Yu L; Faryal R; Mohammad DK; Mohamed AJ; Smith CI
    FEBS J; 2011 Jun; 278(12):2001-10. PubMed ID: 21518255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of 2-((3-Acrylamido-4-methylphenyl)amino)-N-(2-methyl-5-(3,4,5-trimethoxybenzamido)phenyl)-4-(methylamino)pyrimidine-5-carboxamide (CHMFL-BMX-078) as a Highly Potent and Selective Type II Irreversible Bone Marrow Kinase in the X Chromosome (BMX) Kinase Inhibitor.
    Liang X; Lv F; Wang B; Yu K; Wu H; Qi Z; Jiang Z; Chen C; Wang A; Miao W; Wang W; Hu Z; Liu J; Liu X; Zhao Z; Wang L; Zhang S; Ye Z; Wang C; Ren T; Wang Y; Liu Q; Liu J
    J Med Chem; 2017 Mar; 60(5):1793-1816. PubMed ID: 28140585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.